Severe white matter damage in SHANK3 deficiency: a human and translational study.
Sarah JesseHans-Peter MüllerMichael SchoenHarun AsogluJuergen BockmannHans-Juergen HuppertzVolker RascheAlbert C LudolphTobias M BöckersJan KassubekPublished in: Annals of clinical and translational neurology (2019)
In summary, these translational data provide strong evidence that the SHANK3-deficiency-associated pathomechanism presents predominantly with a white matter disease. Further studies should concentrate on the role of SHANK3 during early axonal pathfinding/wiring and in myelin formation.